Literature DB >> 25851617

De novo exon 1 deletion of AUTS2 gene in a patient with autism spectrum disorder and developmental delay: a case report and a brief literature review.

Yi Liu1, Dongmei Zhao2, Rui Dong1, Xiaomeng Yang1, Yanqing Zhang2, Kristiina Tammimies3, Mohammed Uddin3, Stephen W Scherer3,4, Zhongtao Gai1,2.   

Abstract

Exonic deletions disrupting the autism susceptibility candidate 2 (AUTS2) gene have been demonstrated as causal variants leading to neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD) and developmental delay (DD). Here, we report on 830 kb de novo deletion at chromosome 7q11.22 in a 4-year-old male patient with ASD and DD. This deletion disrupts the promoter region and exon 1 of AUTS2, potentially leading to complete haploinsuffiency of the gene. In addition, we discuss the clinical presentation of the de novo deletion in the light of the previous studies describing deletions of AUTS2 in NDDs.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  autism spectrum disorder; autism susceptibility candidate 2; developmental delay; neurodevelopmental disorders

Mesh:

Substances:

Year:  2015        PMID: 25851617     DOI: 10.1002/ajmg.a.37050

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Untangle the Multi-Facet Functions of Auts2 as an Entry Point to Understand Neurodevelopmental Disorders.

Authors:  Wenbin Pang; Xinan Yi; Ling Li; Liyan Liu; Wei Xiang; Le Xiao
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

Review 2.  Fundamental Elements in Autism: From Neurogenesis and Neurite Growth to Synaptic Plasticity.

Authors:  James Gilbert; Heng-Ye Man
Journal:  Front Cell Neurosci       Date:  2017-11-20       Impact factor: 5.505

Review 3.  Neuronal Migration and AUTS2 Syndrome.

Authors:  Kei Hori; Mikio Hoshino
Journal:  Brain Sci       Date:  2017-05-14

4.  CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.

Authors:  Ping Wang; Ryan Mokhtari; Erika Pedrosa; Michael Kirschenbaum; Can Bayrak; Deyou Zheng; Herbert M Lachman
Journal:  Mol Autism       Date:  2017-03-20       Impact factor: 7.509

5.  RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome.

Authors:  Natasha L Pacheco; Michael R Heaven; Leanne M Holt; David K Crossman; Kristin J Boggio; Scott A Shaffer; Daniel L Flint; Michelle L Olsen
Journal:  Mol Autism       Date:  2017-10-24       Impact factor: 7.509

Review 6.  Erotomania and phenotypic continuum in a family frameshift variant of AUTS2: a case report and review.

Authors:  Christophe Gauld; Alice Poisson; Julie Reversat; Elodie Peyroux; Françoise Houdayer-Robert; Massimiliano Rossi; Gaetan Lesca; Damien Sanlaville; Caroline Demily
Journal:  BMC Psychiatry       Date:  2021-07-17       Impact factor: 3.630

7.  The Genetic Architecture of Murine Glutathione Transferases.

Authors:  Lu Lu; Ashutosh K Pandey; M Trevor Houseal; Megan K Mulligan
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

8.  NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.

Authors:  Stefan Nagel; Claudia Pommerenke; Corinna Meyer; Maren Kaufmann; Roderick A F MacLeod; Hans G Drexler
Journal:  Oncotarget       Date:  2017-06-21

9.  Critical exon indexing improves clinical interpretation of copy number variants in neurodevelopmental disorders.

Authors:  E Robert Wassman; Karen S Ho; Diana Bertrand; Kyle W Davis; Megan M Martin; Stephanie Page; Andreas Peiffer; Aparna Prasad; Moises A Serrano; Hope Twede; Rena Vanzo; Stephen W Scherer; Mohammed Uddin; Charles H Hensel
Journal:  Neurol Genet       Date:  2019-12-06

10.  A case of autism spectrum disorder with cleft lip and palate carrying a mutation in exon 8 of AUTS2.

Authors:  Saki Saeki; Takashi Enokizono; Kazuo Imagawa; Hiroko Fukushima; Daigo Kajikawa; Aiko Sakai; Mai Tanaka; Tatsuyuki Ohto; Hisato Suzuki; Tomoko Uehara; Toshiki Takenouchi; Kosaki Kenjiro; Hidetoshi Takada
Journal:  Clin Case Rep       Date:  2019-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.